West Pharmaceutical Services, Inc.

WST · NYSE · USD

Historical Earnings

QuarterReportedEPS estEPS actSurpriseRev estRev actSurpriseReaction
Q2 2026Jul 23, 20262.082.37+13.9%$840.0M$872.3M+3.8%−7.67%
Q1 2026Apr 23, 20261.682.13+26.8%$780.3M$844.9M+8.3%−1.14%
Q4 2025Feb 12, 20261.832.04+11.5%$794.9M$805.0M+1.3%+2.82%
Q3 2025Oct 23, 20251.681.96+16.7%$785.7M$804.3M+2.4%−3.18%
Q2 2025Jul 24, 20251.511.84+21.9%$726.1M$766.2M+5.5%−5.59%
Q1 2025Apr 24, 20251.221.45+18.9%$713.0M$698.0M−2.1%+1.88%
Q4 2024Feb 13, 20251.711.82+6.4%$740.5M$748.8M+1.1%+7.84%
Q3 2024Oct 24, 20241.501.85+23.3%$709.6M$746.9M+5.3%−6.87%

Detailed View

Q3 2026Oct 29, 2026Q2 2026Jul 23, 2026−7.67%Q1 2026Apr 23, 2026−1.14%Q4 2025Feb 12, 2026+2.82%Q3 2025Oct 23, 2025−3.18%Q2 2025Jul 24, 2025−5.59%Q1 2025Apr 24, 2025+1.88%Q4 2024Feb 13, 2025+7.84%Q3 2024Oct 24, 2024−6.87%Q2 2024Jul 25, 2024Q1 2024Apr 25, 2024Q4 2023Feb 15, 2024
2026 Q2 Metrics
MetricEstimateActualSurpriseY/Y
Revenue$840.0M$872.3MBeat +3.85%+13.8%
EPS2.082.37Beat +13.94%+28.8%
Diluted EPS (GAAP)—2.15—+18.1%
Documents